Virtual reality exercise game for improving attention in adolescents with ADHD
Official title: Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD: A Randomized Clinical Trial With 'Move Sapiens®'
Run by Hospital de Clinicas de Porto Alegre · NCT06632249 · Data updated 2026-11-12
This study is testing if a fun virtual reality exercise game can help teenagers with ADHD improve their attention and feel better overall.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 17 Years |
| Sex | All |
| Enrollment | 98 (estimated) |
| Sponsor | Hospital de Clinicas de Porto Alegre Academic / other |
| Locations | 2 sites (Porto Alegre, Rio Grande do Sul and 1 other locations) |
| Status | Recruiting |
| Started | September 13, 2024 |
| Main results expected | July 2026 |
| Study ends | November 2026 |
| Registry record updated | October 9, 2024 |
| Trial ID | NCT06632249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 12 to 17 with a diagnosis of ADHD who have not been on medication for at least one month.
✕Probably not a fit
Patients with severe psychiatric or physical conditions that prevent participation in HIIT or those who are physically active more than twice a week may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of the 'Move Sapiens' virtual reality exergame combined with high-intensity interval training (HIIT) as an intervention for adolescents aged 12 to 17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). Participants will be randomly assigned to either the HIIT VR exergame group or a control group that uses a non-exercise version of the game. The study aims to assess improvements in attention and executive function, as well as reductions in symptoms like sleep problems and anxiety, through validated questionnaires and clinical evaluations. The intervention will take place over 20 sessions across four weeks, with assessments conducted before and after the program.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance attention and executive function in adolescents with ADHD, potentially improving their daily functioning and quality of life.
How similar studies have gone: While the combination of HIIT and VR for ADHD is a novel approach, existing literature suggests that HIIT has shown promise in improving symptoms of ADHD, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * participants with diagnosis of ADHD according to DSM-5; * age between 12 and 17 years; * no prior use of ADHD medication or have not been using ADHD medication for at least one month. Exclusion Criteria: * participants with conditions and comorbidities that prevent the execution of HIIT in VR, such as severe additional psychiatric and physical conditions and a history of seizures; * inattention score below 12 on the SNAP-IV inattention subscale; * IQ below 70; * recreationally active people who engage in intense, systematic physical activity more than two times a week. For the MRI assessment, the following exclusionary criteria are added: * participants with non-compatible aneurysm clips, cochlear implants, pacemakers, metal fragments in the body or eyes, or non-removable piercings; * internal metal residues that interfere with image acquisition and analysis; * severe claustrophobia; * respiratory difficulties that prevent cooperation; * inability to remain still due to hyperactivity; * body weight and size exceeding device limits; * excessive involuntary movement; * anatomical abnormalities.
Where it's running
-
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil Recruiting -
UniEDUK-UniMax
Indaiatuba, São Paulo, Brazil Not yet recruiting
Study contacts
- Principal investigator: Luis Augusto Rohde, PhD — Hospital de Clinicas de Porto Alegre
- Study coordinator: Luis Augusto Rohde, PhD
- Email: larohde@hcpa.edu.br
- Phone: +55 51 33598094
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Foquest in older adults with ADHD: daily methylphenidate for 65+
This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.
-
Neuroplasticity-targeted supplements for ADHD in children
A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Transcranial infrared light to the prefrontal cortex for adults with ADHD
This trial will try using transcranial infrared light on the prefrontal cortex to see if it improves attention, impulse control, and working memory in adults with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.